Corvus Pharmaceuticals, Inc. (CRVS) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Corvus Pharmaceuticals, Inc. (CRVS) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

CRVS Cash Flow Statement

Corvus Pharmaceuticals, Inc. (CRVS) cash flow statement — 12-year operating, investing & financing cash flows

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Cash from Operations	-12.21M	-15.4M	-10.37M	-9.19M	-9.57M	-5.78M	-8.26M	-8.46M	-6.32M	-5.48M	-5.16M	-5.17M	-5.43M	-5.22M	-8.11M	-7.55M	-6.93M	-6.12M	-6.42M	-6.86M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-27.69%	-166.54%	-25.55%	-8.58%	-51.34%	-5.4%	-60.23%	-63.83%	-16.32%	-4.94%	36.42%	31.54%	21.58%	14.7%	-26.26%	-10.08%	17.76%	51.59%	26.89%	16.46%
Net Income	-20.34M	-17.96M	-13.69M	-12.32M	-10.16M	-8M	15.19M	-12.11M	-40.22M	-4.26M	-5.7M	-6.65M	-6M	-6.5M	-7.87M	-9.82M	-14.83M	-8.36M	-8.3M	-9.24M
Depreciation & Amortization	95K	34K	29K	26K	28K	29K	22K	20K	21K	21K	23K	28K	30K	36K	57K	94K	94K	92K	87K	93K
Stock-Based Compensation	2.83M	2.61M	2.65M	1.57M	1.25M	1.26M	1.25M	845K	701K	768K	689K	572K	546K	537K	492K	620K	658K	675K	739K	738K
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	2.7M	2.48M	582K	446K	-136K	-1.96M	-24.88M	4.24M	32.85M	-1.46M	-387K	1.28M	620K	1.03M	1.47M	4.43M	2.65M	1.64M	1.1M	2.59M
Working Capital Changes	2.51M	-2.56M	57K	1.08M	-550K	2.89M	152K	-1.46M	326K	-545K	219K	-391K	-630K	-319K	-2.25M	-2.88M	4.5M	-163K	-49K	-1.04M
Change in Receivables	1K	37K	-6K	-5K	54K	-7K	-4K	-5K	-35K	-9K	0	-15K	-11K	429K	159K	-85K	-130K	0	134K	-231K
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	1.6M	-650K	2.21M	517K	-1.16M	1.83M	-1.27M	709K	660K	-396K	84K	121K	-694K	691K	-569K	-2.25M	1.83M	210K	624K	-769K
Cash from Investing	7.52M	-5.96M	-144.85M	10.88M	-2.62M	-20.3M	4.24M	-6.08M	-3.89M	-17.5M	-7K	-2.32M	17.55M	-4.29M	4.6M	-3.88M	3.04M	3.14M	-25.57M	-2M
Capital Expenditures	-66K	-582K	-91K	-25K	0	-113K	-36K	5K	0	0	0	0	0	0	-34K	-4K	-265K	-4K	0	-5K
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	22K	0	-3.14K	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	-5M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4K	0	3.14K	0	0
Cash from Financing	805K	166K	190.75M	20K	360K	35.77M	279K	18.61M	50K	30.37M	0	0	335K	7.52M	4K	0	0	0	0	18K
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	0	166K	190.75M	20K	360K	35.77M	279K	18.61M	50K	30.37M	0	0	327K	0	0	0	0	0	0	18K
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	805K	0	0	0	0	0	0	0	0	0	0	0	8K	7.52M	4K	0	0	0	0	0
Net Change in Cash	-3.89M	-21.2M	35.53M	1.71M	-11.82M	9.69M	-3.74M	4.06M	-10.16M	7.38M	-5.16M	-7.49M	12.45M	-2M	-3.5M	-11.43M	-3.89M	-2.98M	-32M	-8.84M
Free Cash Flow	-12.28M	-15.98M	-10.46M	-9.22M	-9.57M	-5.89M	-8.3M	-8.46M	-6.32M	-5.48M	-5.16M	-5.17M	-5.43M	-5.22M	-8.14M	-7.55M	-7.19M	-6.13M	-6.42M	-6.86M
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-28.38%	-171.31%	-26.1%	-8.87%	-51.34%	-7.46%	-60.93%	-63.83%	-16.32%	-4.94%	36.69%	31.57%	24.46%	14.75%	-26.79%	-10.06%	14.61%	51.55%	26.89%	16.4%
FCF per Share	-0.13	-0.17	-0.12	-0.12	-0.12	-0.08	-0.11	-0.12	-0.09	-0.09	-0.11	-0.11	-0.11	-0.11	-0.17	-0.16	-0.15	-0.13	-0.14	-0.15
FCF Conversion (FCF/Net Income)	0.60x	0.86x	0.76x	0.75x	0.94x	0.72x	-0.54x	0.70x	0.16x	1.29x	0.90x	0.78x	0.91x	0.80x	1.03x	0.77x	0.47x	0.73x	0.77x	0.74x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0